Skip to main content
For US Healthcare Professionals Only
Quick Links
Prescribing Information
BIMZELX® (bimekizumab-bkzx)
BRIVIACT® (brivaracetam) CV
CIMZIA® (certolizumab pegol)
FINTEPLA® (fenfluramine)
NAYZILAM® (midazolam) CIV
RYSTIGGO® (rozanolixizumab-noli)
ZILBRYSQ® (zilucoplan)
Adverse Event Reporting
Report an Adverse Event or Product Complaint
Email
1-844-599-CARE (2273)
Connect With an MSL
Connect With Us
Main navigation
Home
Our Science
Overview
Publications
Clinical Pipeline
Opportunities for Investigators
Disease Education
Overview
Dermatology
Epilepsy
Rare Disease
Rheumatology
Podcasts
Independent Medical Education
Congress Materials
Medical Information
Overview
Submit Medical Inquiry
Slide Library
HCP Resources
Prescribing Information
Connect With an MSL
Connect With Us
BIMZELX® (bimekizumab-bkzx)
BRIVIACT® (brivaracetam) CV
CIMZIA® (certolizumab pegol)
FINTEPLA® (fenfluramine)
NAYZILAM® (midazolam) CIV
RYSTIGGO® (rozanolixizumab-noli)
ZILBRYSQ® (zilucoplan)
Home
Congress Materials
Congress Materials
Child Neurology Society (CNS), 2024
Filter
Close
Filter
Content type:
Medical Symposium
Oral Presentation
Poster
Video
Apply filters
Caregiver Versus Investigator Clinical Global Impression-Improvement Ratings in Fenfluramine Clinical Trials
Lieven Lagae, Kelly Knupp, J Helen Cross, et al.
Poster
Safety and Effectiveness of Adjunctive Fenfluramine in an Open-Label Extension Study of Children (Under 6 Years Old) With Dravet Syndrome
Ingrid E. Scheffer, Rima Nabbout, Lieven Lagae, et al.
Poster
For US Healthcare Professionals Only
For US Healthcare Professionals Only